D-0325-2021 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0325-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Mar 25, 2021 and is designated Class III. Reason for recall: Failed Moisture Limits: Out of specification for water content The recall status is terminated (terminated Apr 14, 2022). Affected quantity: 2520 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 14, 2021
Initiation Date
Mar 25, 2021
Termination Date
Apr 14, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2520 bottles

Product description

Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda HIghway, Halol-389 350 Gujarat, India, NDC 62756-142-02.

Reason for recall

Failed Moisture Limits: Out of specification for water content

Distribution pattern

Nationwide in the USA

Code information

Lot #JKU4639A, Exp 10/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0325-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0325-2021. Report a data issue: hello@regdatalab.com.